Search for other papers by Ting Zhang in
Current site
Google Scholar
PubMed
Search for other papers by Peng Li in
Current site
Google Scholar
PubMed
Search for other papers by Wanying Guo in
Current site
Google Scholar
PubMed
Search for other papers by Qipeng Liu in
Current site
Google Scholar
PubMed
Search for other papers by Weiqiang Qiao in
Current site
Google Scholar
PubMed
Search for other papers by Miao Deng in
Current site
Google Scholar
PubMed
Abstract
Objective
This study aimed to assess the expression of NCAPH in human breast cancer, and to investigate its effects on breast cancer cells.
Methods
Bioinformation analysis was performed to analyze the expression of NCAPH in human breast cancer tissues and normal tissues in TCGA database. qPCR and Immunoblot assays were performed to clarify the expression of NCAPH in breast cancer tissues and cell lines, respectively. CCK-8, colony formation, FCM, transwell, and immunoblot assays were performed to reveal the effects of NCAPH on breast cancer proliferation, cell cycle, motility and EMT of breast cancer cells. Additionally, immunoblot assays were performed to investigate the effects of NCAPH on the PI3K/AKT pathway in breast cancer.
Results
We found that NCAPH was highly expressed in human breast cancer cell lines. The depletion of NCAPH suppressed the viability of breast cancer cells. Further, we noticed that its downregulation restrained breast cancer cell migration as well as invasion, and the EMT process. Mechanically, we noticed that NCAPH mediated the PI3K/AKT pathway, and therefore contributed to breast cancer progression.
Conclusion
In summary, NCAPH has the potential to serve as a breast cancer target.
-
1.
Romero-Cordoba S , Tagliabue E , Triulzi T , Bianchi F . Deep into breast cancer heterogeneity to increase immunotherapeutic effectiveness. JCO Precis Oncol 2020; 4: 1267–8. https://doi.org/10.1200/PO.20.00313.
-
2.
Park JH , Han HS , Lim SD , Kim WY , Park KS , Yoo YB , et al. Fatty acid synthetase expression in triple-negative breast cancer. J Pathol Transl Med 2022; 56(2): 73–80. https://doi.org/10.4132/jptm.2021.10.27.
-
3.
Ahearn TU , Zhang H , Michailidou K , Milne RL , Bolla MK , Dennis J , et al. Common variants in breast cancer risk loci predispose to distinct tumor subtypes. Breast Cancer Res 2022; 24(1): 2. https://doi.org/10.1186/s13058-021-01484-x.
-
4.
Camilloni A , Nati G , Maggiolini P , Romanelli A , Carbone G , Giannarelli D , et al. Chronic non-cancer pain in primary care: An Italian cross-sectional study. Signa Vitae 2021; 17(2): 54–62. https://doi.org/10.22514/sv.2020.16.0111.
-
5.
Yang ZY , Yin SP , Ren Q , Lu DW , Tang T , Li Y , et al. BAHD1 serves as a critical regulator of breast cancer cell proliferation and invasion. Breast Cancer 2022; 29(3): 516–30. https://doi.org/10.1007/s12282-022-01333-5.
-
6.
Dai R , Peng X , Lin B , Xu D , Lv R . NIR II Luminescence imaging for sentinel lymph node and enhanced chemo-/photothermal therapy for breast cancer. Bioconjug Chem 2021; 32(9): 2117–27. https://doi.org/10.1021/acs.bioconjchem.1c00393.
-
7.
Hickey BE , Lehman M . Partial breast irradiation versus whole breast radiotherapy for early breast cancer. Cochrane Database Syst Rev 2021; 8: CD007077. https://doi.org/10.1002/14651858.CD007077.pub4.
-
8.
Karahaliloglu Z , Kilicay E , Hazer B . Herceptin-conjugated magnetic polystyrene-Agsbox nanoparticles as a theranostic agent for breast cancer. J Biomater Appl 2022; 36(9): 1599–616. https://doi.org/10.1177/08853282211065085.
-
9.
Li B , Xiao Q , Shan L , Song Y . NCAPH promotes cell proliferation and inhibits cell apoptosis of bladder cancer cells through MEK/ERK signaling pathway. Cell Cycle 2022; 21(4): 427–38. https://doi.org/10.1080/15384101.2021.2021050.
-
10.
Wang Y , Li JQ , Yang ZL , Wang L , Zhang JC , Sun YF , et al. NCAPH regulates gastric cancer progression through DNA damage response. Neoplasma 2022; 69(2): 283–91. https://doi.org/10.4149/neo_2021_210607N761.
-
11.
Ryu B , Kim DS , Deluca AM , Alani RM . Comprehensive expression profiling of tumor cell lines identifies molecular signatures of melanoma progression. PLoS One 2007; 2(7): e594. https://doi.org/10.1371/journal.pone.0000594.
-
12.
Kim B , Kim SW , Lim JY , Park SJ . NCAPH is required for proliferation, migration and invasion of non-small-cell lung cancer cells. Anticancer Res 2020; 40(6): 3239–46. https://doi.org/10.21873/anticanres.14305.
-
13.
Cui F , Hu J , Xu Z , Tan J , Tang H . Overexpression of NCAPH is upregulated and predicts a poor prognosis in prostate cancer. Oncol Lett 2019; 17(6): 5768–76. https://doi.org/10.3892/ol.2019.10260.
-
14.
Yin L , Jiang LP , Shen QS , Xiong QX , Zhuo X , Zhang LL , et al. NCAPH plays important roles in human colon cancer. Cell Death Dis 2017; 8(3):e2680. https://doi.org/10.1038/cddis.2017.88.
-
15.
Wang M , Qiao X , Cooper T , Pan W , Liu L , Hayball J , et al. HPV E7-mediated NCAPH ectopic expression regulates the carcinogenesis of cervical carcinoma via PI3K/AKT/SGK pathway. Cell Death Dis 2020; 11(12): 1049. https://doi.org/10.1038/s41419-020-03244-9.
-
16.
Lu H , Shi C , Wang S , Yang C , Wan X , Luo Y , et al. Identification of NCAPH as a biomarker for prognosis of breast cancer. Mol Biol Rep 2020; 47(10): 7831–42. https://doi.org/10.1007/s11033-020-05859-9.
-
17.
Bilgilier C , Fuereder T , Kastner MT , Vass Z , Brandl I , Sahbegovic H , et al. Oral abundance of Actinomyces spp. in breast cancer patients. Oncology 2022; 100(4): 221–7. https://doi.org/10.1159/000522070.
-
18.
Tang L , Jiang W , Wu L , Yu X , He Z , Shan W , et al. TPGS2000-DOX prodrug micelles for improving breast cancer therapy. Int J Nanomedicine 2021; 16: 7875–90. https://doi.org/10.2147/IJN.S335405.
-
19.
Qi Y , Zhao T , Han M . The application of radiomics in predicting gene mutations in cancer. Eur Radiol 2022; 32(6): 4014–24. https://doi.org/10.1007/s00330-021-08520-6.
-
20.
Xiong Q , Fan S , Duan L , Liu B , Jiang X , Chen X , et al. NCAPH is negatively associated with Mcl1 in nonsmall cell lung cancer. Mol Med Rep 2020; 22(4): 2916–24. https://doi.org/10.3892/mmr.2020.11359.
-
21.
Shimomura H , Sasahira T , Nakashima C , Kurihara-Shimomura M , Kirita T . Non-SMC condensin I complex subunit H (NCAPH) is associated with lymphangiogenesis and drug resistance in oral squamous cell carcinoma. J Clin Med 2019; 9(1): 72. https://doi.org/10.3390/jcm9010072.
-
22.
Kim JH , Youn Y , Kim KT , Jang G , Hwang JH . Non-SMC condensin I complex subunit H mediates mature chromosome condensation and DNA damage in pancreatic cancer cells. Sci Rep 2019; 9(1): 17889. https://doi.org/10.1038/s41598-019-54478-3.
-
23.
Li H , Chen M , Yang Z , Xu C , Yu Q , Song J , et al. Amorphophalli Rhizoma inhibits breast cancer growth, proliferation, migration, and invasion via the PI3K/AKT pathway. J Ethnopharmacol 2022; 286: 114926. https://doi.org/10.1016/j.jep.2021.114926.
-
24.
Li J , Zhang C , Jiang H , Cheng J . Andrographolide inhibits hypoxia-inducible factor-1 through phosphatidylinositol 3-kinase/AKT pathway and suppresses breast cancer growth. Onco Targets Ther 2015; 8: 427–35. https://doi.org/10.2147/OTT.S76116.
Editor-in-Chief
László ROSIVALL (Semmelweis University, Budapest, Hungary)
Managing Editor
Anna BERHIDI (Semmelweis University, Budapest, Hungary)
Co-Editors
- Gábor SZÉNÁSI (Semmelweis University, Budapest, Hungary)
- Ákos KOLLER (Semmelweis University, Budapest, Hungary)
- Zsolt RADÁK (University of Physical Education, Budapest, Hungary)
- László LÉNÁRD (University of Pécs, Hungary)
- Zoltán UNGVÁRI (Semmelweis University, Budapest, Hungary)
Assistant Editors
- Gabriella DÖRNYEI (Semmelweis University, Budapest, Hungary)
- Zsuzsanna MIKLÓS (Semmelweis University, Budapest, Hungary)
- György NÁDASY (Semmelweis University, Budapest, Hungary)
Hungarian Editorial Board
- György BENEDEK (University of Szeged, Hungary)
- Zoltán BENYÓ (Semmelweis University, Budapest, Hungary)
- Mihály BOROS (University of Szeged, Hungary)
- László CSERNOCH (University of Debrecen, Hungary)
- Magdolna DANK (Semmelweis University, Budapest, Hungary)
- László DÉTÁRI (Eötvös Loránd University, Budapest, Hungary)
- Zoltán GIRICZ (Semmelweis University, Budapest, Hungary and Pharmahungary Group, Szeged, Hungary)
- Zoltán HANTOS (Semmelweis University, Budapest and University of Szeged, Hungary)
- Zoltán HEROLD (Semmelweis University, Budapest, Hungary)
- László HUNYADI (Semmelweis University, Budapest, Hungary)
- Gábor JANCSÓ (University of Pécs, Hungary)
- Zoltán KARÁDI (University of Pecs, Hungary)
- Miklós PALKOVITS (Semmelweis University, Budapest, Hungary)
- Gyula PAPP (University of Szeged, Hungary)
- Gábor PAVLIK (University of Physical Education, Budapest, Hungary)
- András SPÄT (Semmelweis University, Budapest, Hungary)
- Gyula SZABÓ (University of Szeged, Hungary)
- Zoltán SZELÉNYI (University of Pécs, Hungary)
- Lajos SZOLLÁR (Semmelweis University, Budapest, Hungary)
- József TOLDI (MTA-SZTE Neuroscience Research Group and University of Szeged, Hungary)
- Árpád TÓSAKI (University of Debrecen, Hungary)
International Editorial Board
- Dragan DJURIC (University of Belgrade, Serbia)
- Christopher H. FRY (University of Bristol, UK)
- Stephen E. GREENWALD (Blizard Institute, Barts and Queen Mary University of London, UK)
- Tibor HORTOBÁGYI (University of Groningen, Netherlands)
- George KUNOS (National Institutes of Health, Bethesda, USA)
- Massoud MAHMOUDIAN (Iran University of Medical Sciences, Tehran, Iran)
- Tadaaki MANO (Gifu University of Medical Science, Japan)
- Luis Gabriel NAVAR (Tulane University School of Medicine, New Orleans, USA)
- Hitoo NISHINO (Nagoya City University, Japan)
- Ole H. PETERSEN (Cardiff University, UK)
- Ulrich POHL (German Centre for Cardiovascular Research and Ludwig-Maximilians-University, Planegg, Germany)
- Andrej A. ROMANOVSKY (University of Arizona, USA)
- Anwar Ali SIDDIQUI (Aga Khan University, Karachi, Pakistan)
- Csaba SZABÓ (University of Fribourg, Switzerland)
- Eric VICAUT (Université de Paris, UMRS 942 INSERM, France)
Editorial Correspondence:
Physiology International
Semmelweis University
Faculty of Medicine, Institute of Translational Medicine
Nagyvárad tér 4, H-1089 Budapest, Hungary
Phone/Fax: +36-1-2100-100
E-mail: pi@semmelweis.hu
Indexing and Abstracting Services:
- Biological Abstracts
- BIOSIS Previews
- CAB Abstracts
- CABELLS Journalytics
- EMBASE/Excerpta Medica
- Global Health
- Index Copernicus
- Index Medicus
- Medline
- Referativnyi Zhurnal
- SCOPUS
- WoS - Science Citation Index Expanded
| 2023 | |
|---|---|
| Web of Science | |
| Journal Impact Factor | 2.2 |
| Rank by Impact Factor | Q3 (Physiology) |
| Journal Citation Indicator | 0.58 |
| Scopus | |
| CiteScore | 3.4 |
| CiteScore rank | Q2 (Physical Therapy, Sports Therapy and Rehabilitation) |
| SNIP | 0.508 |
| Scimago | |
| SJR index | 0.407 |
| SJR Q rank | Q2 |
| Physiology International | |
|---|---|
| Publication Model | Hybrid |
| Submission Fee | none |
| Article Processing Charge | 1100 EUR/article |
| Printed Color Illustrations | 40 EUR (or 10 000 HUF) + VAT / piece |
| Regional discounts on country of the funding agency | World Bank Lower-middle-income economies: 50% World Bank Low-income economies: 100% |
| Further Discounts | Editorial Board / Advisory Board members: 50% Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100% |
| Subscription fee 2025 | Online subsscription: 752 EUR / 828 USD Print + online subscription: 880 EUR / 968 USD |
| Subscription Information | Online subscribers are entitled access to all back issues published by Akadémiai Kiadó for each title for the duration of the subscription, as well as Online First content for the subscribed content. |
| Purchase per Title | Individual articles are sold on the displayed price. |
| Physiology International | |
|---|---|
| Language | English |
| Size | B5 |
| Year of Foundation |
2006 (1950) |
| Volumes per Year |
1 |
| Issues per Year |
4 |
| Founder | Magyar Tudományos Akadémia |
| Founder's Address |
H-1051 Budapest, Hungary, Széchenyi István tér 9. |
| Publisher | Akadémiai Kiadó |
| Publisher's Address |
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245. |
| Responsible Publisher |
Chief Executive Officer, Akadémiai Kiadó |
| ISSN | 2498-602X (Print) |
| ISSN | 2677-0164 (Online) |
Monthly Content Usage
| Abstract Views | Full Text Views | PDF Downloads | |
|---|---|---|---|
| Jun 2024 | 55 | 0 | 0 |
| Jul 2024 | 37 | 0 | 0 |
| Aug 2024 | 53 | 0 | 0 |
| Sep 2024 | 67 | 0 | 0 |
| Oct 2024 | 132 | 1 | 1 |
| Nov 2024 | 83 | 0 | 0 |
| Dec 2024 | 18 | 0 | 0 |
Copyright Akadémiai Kiadó AKJournals is the trademark of Akadémiai Kiadó's journal publishing business branch.